BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11885027)

  • 21. Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy.
    Alvarez K; Fadic R; Brandan E
    J Cell Biochem; 2002; 85(4):703-13. PubMed ID: 11968010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions.
    Nikitovic D; Zafiropoulos A; Tzanakakis GN; Karamanos NK; Tsatsakis AM
    Anticancer Res; 2005; 25(4):2851-6. PubMed ID: 16080537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Osteopontin in tumor metastasis.
    Wai PY; Kuo PC
    J Surg Res; 2004 Oct; 121(2):228-41. PubMed ID: 15501463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of cell-membrane and extracellular proteoglycans in monkey submandibular gland.
    Okuda H; Kamada A
    J Osaka Dent Univ; 1999 Oct; 33(2):59-64. PubMed ID: 10863476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the role of extracellular matrix during tumor onset and progression.
    Pupa SM; Ménard S; Forti S; Tagliabue E
    J Cell Physiol; 2002 Sep; 192(3):259-67. PubMed ID: 12124771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone-specific heparan sulfates induce osteoblast growth arrest and downregulation of retinoblastoma protein.
    Manton KJ; Sadasivam M; Cool SM; Nurcombe V
    J Cell Physiol; 2006 Oct; 209(1):219-29. PubMed ID: 16826571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparan sulphate proteoglycans: the sweet side of development.
    Häcker U; Nybakken K; Perrimon N
    Nat Rev Mol Cell Biol; 2005 Jul; 6(7):530-41. PubMed ID: 16072037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.
    Tímár J; Lapis K; Dudás J; Sebestyén A; Kopper L; Kovalszky I
    Semin Cancer Biol; 2002 Jun; 12(3):173-86. PubMed ID: 12083848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparan sulfate proteoglycans: structure, protein interactions and cell signaling.
    Dreyfuss JL; Regatieri CV; Jarrouge TR; Cavalheiro RP; Sampaio LO; Nader HB
    An Acad Bras Cienc; 2009 Sep; 81(3):409-29. PubMed ID: 19722012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of Growth Factor response in brain tumors by complex carbohydrates.
    Rebbaa A; Chou PM; Bremer EG
    Bull Cancer; 2004 Apr; 91(4):E15-60. PubMed ID: 15562557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycomics approach to structure-function relationships of glycosaminoglycans.
    Sasisekharan R; Raman R; Prabhakar V
    Annu Rev Biomed Eng; 2006; 8():181-231. PubMed ID: 16834555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
    Winkler S; Stahl RC; Carey DJ; Bansal R
    J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of integrins and tissue matrix in the progression of the neoplastic process].
    Flak A; Sułkowski P; Gmiński J
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):562-4. PubMed ID: 1480531
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteoglycans in the control of tumor growth and metastasis formation.
    Cattaruzza S; Nicolosi PA; Perris R
    Connect Tissue Res; 2008; 49(3):225-9. PubMed ID: 18661348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
    Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
    Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparan Sulfate Proteoglycans Can Promote Opposite Effects on Adhesion and Directional Migration of Different Cancer Cells.
    Depau L; Brunetti J; Falciani C; Mandarini E; Riolo G; Zanchi M; Karousou E; Passi A; Pini A; Bracci L
    J Med Chem; 2020 Dec; 63(24):15997-16011. PubMed ID: 33284606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ROS-major mediators of extracellular matrix remodeling during tumor progression.
    Nikitovic D; Corsini E; Kouretas D; Tsatsakis A; Tzanakakis G
    Food Chem Toxicol; 2013 Nov; 61():178-86. PubMed ID: 23792086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis.
    Kirn-Safran CB; Gomes RR; Brown AJ; Carson DD
    Birth Defects Res C Embryo Today; 2004 Mar; 72(1):69-88. PubMed ID: 15054905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.